PI3Kβ selective inhibitor

PI3Kβ inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PI3Kβ selective inhibitor, covering 2025-01-24 to 2025-01-24. Get the full timeline:

Most recent: Clinical Trial Update: PI3Kβ Selective Inhibitor With Paclitaxel, Advanced Gastric Adenocarcinoma [Phase 1, Phase 2]